Antibiotics in the treatment of acute exacerbations of chronic bronchitis. - Wikidata - awgldk - TriplyDB

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

http://www.wikidata.org/entity/Q34706968

about

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.Short-course fluoroquinolones in acute exacerbations of chronic bronchitis.Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).Antimicrobial resistance among respiratory Haemophilus influenzae isolates from pulmonology services over a six-year period.

P2860

Q35096997-4C5D7E6B-6FEA-4CDA-A32D-2E080C282A47 Q35694431-019B947A-CB27-49A9-8C5F-81D2C855BD5D Q36087058-40296BCF-179E-4C76-8F64-64AC40119279 Q37224498-2E620E2D-CD8E-42F7-96AA-AA26CEA5C857 Q37798032-DCF6017E-9608-4991-A8BD-C2C255DB051C Q37814698-D1AF17BF-0023-48F1-A504-78D1BB7AA4E6 Q43428329-1EDA9A54-B2A5-4878-8353-A1120383B0CF

P2860

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

http://www.wikidata.org/entity/Q34706968

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

@ast

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

@en

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

@nl

type

label

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

@ast

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

@en

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

@nl

prefLabel

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

@ast

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

@en

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

@nl

P1433

Q34706968-C66FE78E-EB88-4666-BACB-600A5414F4FE

P1476

Q34706968-0CA606B2-1E7D-4D9E-ABE1-4E1D2183F1B3

P2093

Q34706968-072398D3-731E-4D08-B78F-F73025585CCE

Q34706968-2410A97D-5433-475E-9EB1-BDA561B3985E

Q34706968-D48CADFC-9D61-4B65-BE82-6E2A1A2B5E5E

P2860

Q34706968-0A0D27CB-D83D-4606-B82B-2DB314027621

Q34706968-0AA9BFD8-9145-40C7-B61F-C059369C99FE

Q34706968-10236290-C6FC-4F3D-9690-493A460F17D9

Q34706968-2B977760-9549-4DEC-B162-EC5315BB3387

Q34706968-352BE2B5-6BA8-4A31-862B-9CF2B36047A6

Q34706968-51CD9FC4-3D75-49ED-9F0D-C279D6F7880A

Q34706968-57D322B1-7632-451D-85A0-2697147C8122

Q34706968-66E3C93C-4C83-4CFE-9CB3-727049CFB48F

Q34706968-6856EF63-072E-4FB6-A118-E12605D724A8

Q34706968-6A098879-B0BA-47E8-80A6-E270A2F1A177

P304

Q34706968-0C8F9098-A6DD-45F7-B9B7-7026A47925B8

P31

Q34706968-E5C3156B-0877-4229-A195-74986D0ED0CD

P356

Q34706968-0B7A34A9-1A53-4415-825A-A48DC68243FA

P407

Q34706968-8332E5D8-BE8F-4D49-957E-568C4A859C9A

P433

Q34706968-78000378-1B84-440F-BD5D-59F1E5B77A6E

P478

Q34706968-0DC73387-B624-4F7A-A6C7-791D1EF5AC1A

P577

Q34706968-BD4EAB32-BC9A-488D-8FDB-B3D269CB8508

P698

Q34706968-8217E9FA-783A-4D5A-8382-E1CDDAEF85FA

P356

13543784.11.7.911

P1433

Expert Opinion on Investigational Drugs

P1476

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

@en

P2093

Kavitha Shashikumar

http://www.w3.org/2001/XMLSchema#string

Lisa L Dever

http://www.w3.org/2001/XMLSchema#string

W G Johanson

http://www.w3.org/2001/XMLSchema#string

P2860

A critical review of the fluoroquinolones: focus on respiratory infections

Mortality by cause for eight regions of the world: Global Burden of Disease Study

Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza.

Advances in DNA gyrase inhibitors.

Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections.

Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis.

A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics.

Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance.

Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters.

Moraxella catarrhalis: from emerging to established pathogen.

P304

911-925

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.11.7.911

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12084002

http://www.w3.org/2001/XMLSchema#string